{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T18:11:22Z","timestamp":1789841482192,"version":"4.0.1"},"reference-count":44,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T00:00:00Z","timestamp":1604016000000},"content-version":"vor","delay-in-days":1033,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"content-domain":{"domain":["esmoopen.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["ESMO Open"],"published-print":{"date-parts":[[2018]]},"DOI":"10.1136\/esmoopen-2018-000335","type":"journal-article","created":{"date-parts":[[2018,4,7]],"date-time":"2018-04-07T03:45:13Z","timestamp":1523072713000},"page":"e000335","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT\/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece"],"prefix":"10.1016","volume":"3","author":[{"given":"Leonidas","family":"Mavroeidis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vassiliki","family":"Metaxa-Mariatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Papoudou-Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angeliki Maria","family":"Lampraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lida","family":"Kostadima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilias","family":"Tsinokou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Zarkavelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Papadaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Petrakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"G\u03baoura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Kampletsas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Nasioulas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Batistatou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Pentheroudakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1136\/esmoopen-2018-000335_bb0010","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.5858\/2006-130-1466-GSTROM","article-title":"Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis","volume":"130","author":"Miettinen","year":"2006","journal-title":"Arch Pathol Lab Med"},{"key":"10.1136\/esmoopen-2018-000335_bb0015","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00000478-198309000-00001","article-title":"Reappraisal of histogenesis","volume":"7","author":"Mazur","year":"1983","journal-title":"Am J Surg Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0020","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.canep.2015.10.031","article-title":"Global epidemiology of gastrointestinal stromal tumours (GIST): A systematic review of population-based cohort studies","volume":"40","author":"S\u00f8reide","year":"2016","journal-title":"Cancer Epidemiol"},{"key":"10.1136\/esmoopen-2018-000335_bb0025","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1126\/science.279.5350.577","article-title":"Gain-of-function mutations of c-kit in human gastrointestinal stromal tumors","volume":"279","author":"Hirota","year":"1998","journal-title":"Science"},{"key":"10.1136\/esmoopen-2018-000335_bb0030","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1126\/science.1079666","article-title":"PDGFRA activating mutations in gastrointestinal stromal tumors","volume":"299","author":"Heinrich","year":"2003","journal-title":"Science"},{"key":"10.1136\/esmoopen-2018-000335_bb0035","first-page":"1259","article-title":"Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal","volume":"152","author":"Kindblom","year":"1998","journal-title":"Am J Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0040","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1146\/annurev.pathmechdis.3.121806.151538","article-title":"Molecular pathobiology of gastrointestinal stromal sarcomas","volume":"3","author":"Corless","year":"2008","journal-title":"Annu Rev Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0045","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1365-2559.2010.03624.x","article-title":"DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours","volume":"57","author":"Novelli","year":"2010","journal-title":"Histopathology"},{"key":"10.1136\/esmoopen-2018-000335_bb0050","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1053\/j.semdp.2006.08.006","article-title":"KIT and PDGFRA mutations in gastrointestinal stromal tumors (GISTs)","volume":"23","author":"Lasota","year":"2006","journal-title":"Semin Diagn Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0055","doi-asserted-by":"crossref","first-page":"4342","DOI":"10.1200\/JCO.2003.04.190","article-title":"Kinase mutations and imatinib response in patients with metastatic gastrointestinal stromal tumor","volume":"21","author":"Heinrich","year":"2003","journal-title":"J Clin Oncol"},{"issue":"Suppl 3","key":"10.1136\/esmoopen-2018-000335_bb0060","first-page":"iii21","article-title":"Gastrointestinal stromal tumours: ESMO clinical practice guidelines for diagnosis, treatment and follow-up","volume":"25","author":"ESMO\/European Sarcoma Network Working Group","year":"2014","journal-title":"Ann Oncol"},{"key":"10.1136\/esmoopen-2018-000335_bb0065","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1177\/1758834012450935","article-title":"Current and emerging strategies for the management of imatinib-refractory advanced gastrointestinal stromal tumors","volume":"4","author":"Kee","year":"2012","journal-title":"Ther Adv Med Oncol"},{"issue":"Suppl 1","key":"10.1136\/esmoopen-2018-000335_bb0070","doi-asserted-by":"crossref","first-page":"BIC.S25045","DOI":"10.4137\/BIC.S25045","article-title":"Gastrointestinal stromal tumors (GIST): a prospective analysis and an update on biomarkers and current treatment concepts","volume":"7","author":"Koumarianou","year":"2015","journal-title":"Biomark Cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0075","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.3748\/wjg.14.1891","article-title":"KIT exon 11 codon 557\/558 deletion\/insertion mutations define a subset of gastrointestinal stromal tumors with malignant potential","volume":"14","author":"Kontogianni-Katsarou","year":"2008","journal-title":"World J Gastroenterol"},{"key":"10.1136\/esmoopen-2018-000335_bb0080","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1016\/j.ejca.2006.01.030","article-title":"KIT mutations and dose selection for imatinib in patients with advanced gastrointestinal stromal tumours","volume":"42","author":"Debiec-Rychter","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0085","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/sj.bjc.6605743","article-title":"A prospective epidemiological study of new incident GISTs during two consecutive years in Rh\u00f4ne Alpes region: incidence and molecular distribution of GIST in a European region","volume":"103","author":"Cassier","year":"2010","journal-title":"Br J Cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0090","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1200\/JCO.2014.57.4970","article-title":"KIT and PDGFRA mutations and the risk of GI stromal tumor recurrence","volume":"33","author":"Joensuu","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1136\/esmoopen-2018-000335_bb0095","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.1600-0463.2007.apm_587.x","article-title":"Mutations in gastrointestinal stromal tumors\u00a0\u2013 a population-based study from Northern Norway","volume":"115","author":"Steigen","year":"2007","journal-title":"APMIS"},{"key":"10.1136\/esmoopen-2018-000335_bb0100","first-page":"1379","article-title":"Epidemiology and molecular biology of gastrointestinal stromal tumors (GISTs): a population-based study in the South of Switzerland, 1999-2005","volume":"23","author":"Mazzola","year":"2008","journal-title":"Histol Histopathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0105","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/annonc\/mdr127","article-title":"Prognostic value of KIT\/PDGFRA mutations in gastrointestinal stromal tumours (GIST): Polish Clinical GIST Registry experience","volume":"23","author":"Wozniak","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1136\/esmoopen-2018-000335_bb0110","first-page":"2407","article-title":"Prognostic relevance of KIT and PDGFRA mutations in gastrointestinal stromal tumors","volume":"30","author":"Braggio","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1136\/esmoopen-2018-000335_bb0115","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1002\/jso.21104","article-title":"The analysis of status and clinical implication of KIT and PDGFRA mutations in gastrointestinal stromal tumor (GIST)","volume":"98","author":"Du","year":"2008","journal-title":"J Surg Oncol"},{"key":"10.1136\/esmoopen-2018-000335_bb0120","article-title":"Gastrointestinal stromal tumors, somatic mutations and candidate genetic risk variants","volume":"8","author":"O\u2019Brien","year":"2013","journal-title":"PLoS One"},{"key":"10.1136\/esmoopen-2018-000335_bb0125","doi-asserted-by":"crossref","first-page":"6105","DOI":"10.1158\/1078-0432.CCR-14-1677","article-title":"Tumor genotype is an independent prognostic factor in primary gastrointestinal stromal tumors of gastric origin: a european multicenter analysis based on ConticaGIST","volume":"20","author":"Wozniak","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1136\/esmoopen-2018-000335_bb0130","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/ijc.11323","article-title":"Deletion of Trp-557 and Lys-558 in the juxtamembrane domain of the c-kit protooncogene is associated with metastatic behavior of gastrointestinal stromal tumors","volume":"106","author":"Wardelmann","year":"2003","journal-title":"Int J Cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0135","doi-asserted-by":"crossref","first-page":"13718","DOI":"10.1038\/srep13718","article-title":"Clinicopathological significance of c-KIT mutation in gastrointestinal stromal tumors: a systematic review and meta-analysis","volume":"5","author":"Yan","year":"2015","journal-title":"Sci Rep"},{"issue":"Suppl 1","key":"10.1136\/esmoopen-2018-000335_bb0140","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1038\/modpathol.2013.173","article-title":"Gastrointestinal stromal tumors: what do we know now?","volume":"27 Suppl 1","author":"Corless","year":"2014","journal-title":"Mod Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0145","article-title":"Novel V600E BRAF mutations in imatinib-naive and imatinib-resistant gastrointestinal stromal tumors","volume":"47","author":"Agaram","year":"2008","journal-title":"Genes: chromosomes & cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0150","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1136\/jcp.2009.064550","article-title":"V600E BRAF mutations are alternative early molecular events in a subset of KIT\/PDGFRA wild-type gastrointestinal stromal tumours","volume":"62","author":"Agaimy","year":"2009","journal-title":"J Clin Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0155","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.canlet.2011.07.029","article-title":"Spectrum of KIT\/PDGFRA\/BRAF mutations and Phosphatidylinositol-3-Kinase pathway gene alterations in gastrointestinal stromal tumors (GIST)","volume":"312","author":"Daniels","year":"2011","journal-title":"Cancer Lett"},{"key":"10.1136\/esmoopen-2018-000335_bb0160","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1365-2559.2009.03323.x","article-title":"Low frequency of MAP kinase pathway alterations in KIT and PDGFRA wild-type GISTs","volume":"55","author":"Martinho","year":"2009","journal-title":"Histopathology"},{"key":"10.1136\/esmoopen-2018-000335_bb0165","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1309\/AJCPPCKGA2QGBJ1R","article-title":"BRAF mutation status in gastrointestinal stromal tumors","volume":"133","author":"Hostein","year":"2010","journal-title":"Am J Clin Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0170","doi-asserted-by":"crossref","first-page":"310","DOI":"10.18632\/oncotarget.864","article-title":"BRAF mutant gastrointestinal stromal tumor: first report of regression with BRAF inhibitor dabrafenib (GSK2118436) and whole exomic sequencing for analysis of acquired resistance","volume":"4","author":"Falchook","year":"2013","journal-title":"Oncotarget"},{"key":"10.1136\/esmoopen-2018-000335_bb0175","doi-asserted-by":"crossref","first-page":"30109","DOI":"10.18632\/oncotarget.8768","article-title":"Concomitant KIT\/BRAF and PDGFRA\/BRAF mutations are rare events in gastrointestinal stromal tumors","volume":"7","author":"Rossi","year":"2016","journal-title":"Oncotarget"},{"key":"10.1136\/esmoopen-2018-000335_bb0180","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1158\/1078-0432.CCR-11-2230","article-title":"KRAS and BRAF mutations predict primary resistance to imatinib in gastrointestinal stromal tumors","volume":"18","author":"Miranda","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1136\/esmoopen-2018-000335_bb0185","doi-asserted-by":"crossref","first-page":"16052","DOI":"10.18632\/oncotarget.14109","article-title":"Inhibition of the fibroblast growth factor receptor (FGFR) pathway: the current landscape and barriers to clinical application","volume":"8","author":"Chae","year":"2017","journal-title":"Oncotarget"},{"key":"10.1136\/esmoopen-2018-000335_bb0190","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12967-016-1075-6","article-title":"FGFR1 and NTRK3 actionable alterations in \u201cWild-Type\u201d gastrointestinal stromal tumors","volume":"14","author":"Shi","year":"2016","journal-title":"J Transl Med"},{"key":"10.1136\/esmoopen-2018-000335_bb0195","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1158\/0008-5472.CAN-14-0573","article-title":"Crosstalk between KIT and FGFR3 Promotes Gastrointestinal Stromal Tumor Cell Growth and Drug Resistance","volume":"75","author":"Javidi-Sharifi","year":"2015","journal-title":"Cancer Res"},{"key":"10.1136\/esmoopen-2018-000335_bb0200","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1038\/modpathol.2013.89","article-title":"No KRAS mutations found in gastrointestinal stromal tumors (GISTs): molecular genetic study of 514 cases","volume":"26","author":"Lasota","year":"2013","journal-title":"Mod Pathol"},{"key":"10.1136\/esmoopen-2018-000335_bb0205","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1007\/s10120-012-0213-y","article-title":"Molecular characterization of an Italian series of sporadic GISTs","volume":"16","author":"Origone","year":"2013","journal-title":"Gastric Cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0210","first-page":"177","article-title":"Novel oncogene and tumor suppressor mutations in KIT and PDGFRA wild type gastrointestinal stromal tumors revealed by next generation sequencing","volume":"54","author":"Hechtman","year":"2015","journal-title":"Genes: chromosomes & cancer"},{"key":"10.1136\/esmoopen-2018-000335_bb0215","doi-asserted-by":"crossref","first-page":"30241","DOI":"10.18632\/oncotarget.7148","article-title":"Intratumoral KIT mutational heterogeneity and recurrent KIT\/ PDGFRA mutations in KIT\/PDGFRA wild-type gastrointestinal stromal tumors","volume":"7","author":"Gao","year":"2016","journal-title":"Oncotarget"},{"key":"10.1136\/esmoopen-2018-000335_bb0220","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jamaoncol.2016.0891","article-title":"Landscape of phosphatidylinositol-3-kinase pathway alterations across 19\u202f784 diverse solid tumors","volume":"2","author":"Millis","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1136\/esmoopen-2018-000335_bb0225","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1038\/modpathol.2015.160","article-title":"Frequency and clinicopathologic profile of PIK3CA mutant GISTs: molecular genetic study of 529 cases","volume":"29","author":"Lasota","year":"2016","journal-title":"Mod Pathol"}],"container-title":["ESMO Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292032322X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S205970292032322X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/esmoopen-2018-000335","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T20:22:12Z","timestamp":1761855732000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S205970292032322X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018]]},"references-count":44,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018]]}},"alternative-id":["S205970292032322X"],"URL":"https:\/\/doi.org\/10.1136\/esmoopen-2018-000335","relation":{},"ISSN":["2059-7029"],"issn-type":[{"value":"2059-7029","type":"print"}],"subject":[],"published":{"date-parts":[[2018]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comprehensive molecular screening by next generation sequencing reveals a distinctive mutational profile of KIT\/PDGFRA genes and novel genomic alterations: results from a 20-year cohort of patients with GIST from north-western Greece","name":"articletitle","label":"Article Title"},{"value":"ESMO Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1136\/esmoopen-2018-000335","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 THE AUTHORS. Published by Elsevier Limited on behalf of European Society for Medical Oncology; Originally published by BMJ.","name":"copyright","label":"Copyright"}],"article-number":"e000335"}}